Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies
Clinical trial NCT02721043 · COMPLETED
Trial details
- NCT number
- NCT02721043
- Sponsor
- Nina Bhardwaj
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-11-12
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.